Xencor | XNCR - Ativos

Preço das Ações
12.42
Mudança Diária
-0.11 -0.88%
Mensal
3.16%
Anual
45.43%
Q2 Previsão
12.08




Ativos Alterar Data
AbbVie USD 133.96B 62M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Biogen USD 29.44B 232M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cytokinetics USD 1.42B 12.02M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
J&J USD 199.21B 6.39B 2025-12
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merck USD 129.55B 12.02B 2025-09
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Xencor USD 875.5M 6.68M 2025-12